These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6100426)

  • 1. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.
    Anton PA; Kemp JA; Butler T; Jacobs MR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):312-5. PubMed ID: 6100426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.
    Butler T; Shuster CW; Dixon P
    Antimicrob Agents Chemother; 1981 Feb; 19(2):328-31. PubMed ID: 6289730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
    Nauciel C; Martin E
    Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value addition in the efficacy of conventional antibiotics by Nisin against Salmonella.
    Singh AP; Prabha V; Rishi P
    PLoS One; 2013; 8(10):e76844. PubMed ID: 24116175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
    Landesman SH; Corrado ML; Cherubin CE; Sierra MF
    Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
    Anderson EL; Robinson PA; Tu KK; Adams CR
    South Med J; 1985 Jun; 78(6):643-6. PubMed ID: 3873708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
    Beskid G; Christenson JG; Cleeland R; DeLorenzo W; Trown PW
    Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
    Gooch WM; Daly JA
    Antimicrob Agents Chemother; 1985 Aug; 28(2):343-6. PubMed ID: 3879661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
    Bergeron MG; Claveau S; Simard P
    Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
    Dabernat HJ; Delmas C
    Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice.
    Butler T; Girard AE
    J Antimicrob Chemother; 1993 Feb; 31(2):313-9. PubMed ID: 8385094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic efficacy of cefotaxime and failure of fosfomycin in murine Salmonella typhimurium infection.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1984; 30(3):148-57. PubMed ID: 6329607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of amoxicillin and ampicillin against infection with Salmonella typhimurium in mice ].
    Avril JL; Moyen EN; Fauchere JL; Descamps P; Veron M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):484-7. PubMed ID: 6750518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
    Fattal E; Youssef M; Couvreur P; Andremont A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1540-3. PubMed ID: 2684009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC; Ehret J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.